Genpharmasec Share Price

CMP as on20-May-22 15:53

₹ 5.17
-0.1 -1.9%

Open

₹ 5.33

Turnover (lac)

₹ 10

Prev. Close

₹ 5.27

Day's Vol (shares)

₹ 2,82,675

Day's Range

₹ 5.04
₹ 5.33

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Feb-2022 - -
Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Intimation of Board Meeting to be held on Monday 14th February 2022 at 05.00 P.M Outcome of Board Meeting held on Monday, 14th February, 2022 at 05.00 P. M. Resignation of Mr. Vivek Anand Oberoi, from the post of Chief Strategy Officer (CSO) of the Company w.e.f February 14, 2022 due to his pre- occupation in other assignments. (As per BSE Announcement Dated on 14/02/2022)
Board Meeting - 02-Nov-2021 - -
Quarterly Results Outcome of Board Meeting held on Thursday, 11th November, 2021 at 05.00 P. M. (As Per BSE Announcement Dated 11.11.2021)
Board Meeting - 06-Sep-2021 - -
Intimation For Cut-Off Date And Notice Of Closure Of Register Of Members And Share Transfer Books For The Purpose Of AGM For FY 2020-2021. Outcome of Board Meeting held on 06th September 2021.
Board Meeting - 04-Aug-2021 - -
Generic Pharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve 1. The Un-Audited Financial Results along with Limited Review Report for the Quarter ended on June 30, 2021 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. The appointment of M/s. Meenakshi Manish Jain & Associates, Chartered Accountants, as an Internal Auditor of the Company for financial year 2021-2022. 1. The Un-Audited Financial Results along with Limited Review Report for the Quarter ended 30th June 2021 prepared in terms of IND-AS, pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirement,) Regulation 2015. 2. Appointment of Ms. Nikhita Pais, as an Additional Director (Non -Executive Independent) on the Board of the Company w.e.f August 12, 2021 to hold office till the conclusion of the next Annual General Meeting and subject to the approval of the members in the ensuing General Meeting, for appointment as an Independent Director to hold office for a term up to 5 (five) Consecutive years from August 12, 2021. and other items as attached with the outcome 1. The Un-Audited Financial Results along with Limited Review Report for the Quarter ended 30th June 2021 prepared in terms of IND-AS, pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirement,) Regulation 2015. 2. Appointment of Ms. Nikhita Pais, as an Additional Director (Non -Executive Independent) on the Board of the Company w.e.f August 12, 2021 to hold office till the conclusion of the next Annual General Meeting and subject to the approval of the members in the ensuing General Meeting, for appointment as an Independent Director to hold office for a term up to 5 (five) Consecutive years from August 12, 2021. Brief Profile of Ms. Nikhita Pais and the details required under Regulation 30 of Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is given in the enclosed Annexure. and other items as attached in the outcome 1. Appointment of Ms. Nikhita Pais, as an Additional Director (Non -Executive Independent) on the Board. 2. Resignation of Mrs. Veda Adhatrao Bhushan [DIN 07149680] from the post of Non - executive Independent Director of the Company (As per BSE Announcement Dated on 12/8/2021)
Board Meeting - 22-Jun-2021 - -
Generic Pharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve This is to inform you that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 29th June, 2021 at 04:00 P.M at its registered office to inter-alia:- 1. To consider and approve the Audited Financial Results of the company for the Quarter and Financial Year ended on 31st March, 2021, Statement of Assets and Liabilities and Cash Flow Statement as on 31st March, 2021, as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. To consider and approve the appointment of M/s. Jaymin Modi & Co, Practicing Company Secretary as the Secretarial Auditor of the Company for financial year 2021-2022. 3. Any other matter with the permission of the Chair. Outcome of Board Meeting - delay in submission of Audited Financial Results of the company for the Quarter and Financial Year ended on 31st March, 2021 Resignation of Mr. Dollar Azad Chheda from the post of Directorship and Chief Financial Officer (Key Managerial Personnel) of the Company Outcome of Board Meeting held onTuesday,29th June, 2021. (AS Per BSE Announcement Dated on 29.06.2021) Outcome of Adjourned Meeting of Board of Director held on Friday 02nd July 2021. (As Per BSE Announcement Dated on 02.07.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity